By continuing to use this site you consent to the use of cookies on your device as described in our
Cookie Policy unless you have disabled them. You can change your Cookie Settings at any time but parts of our site will not function correctly without them.

The World Health Organisation (WHO) today published its first 'essential diagnostics list', a catalogue of tests needed to diagnose the most common conditions as well as a number of global priority diseases.

The step was taken to address the problem of people's inability to access diagnostic services, thus failing to receive the correct treatment.

"An accurate diagnosis is the first step to getting effective treatment. No one should suffer or die because of lack of diagnostic services, or because the right tests were not available, said Tedros Adhanom Ghebreyesus, WHO Director-General.

An estimated 46 per cent of adults with Type 2 diabetes worldwide are undiagnosed, risking serious health complications and higher health costs, said a statement by the world health body.

Late diagnosis of infectious diseases such as HIV and tuberculosis increases the risk of their spread and makes them more difficult to treat, it said.

The essential diagnostics list concentrates on in vitro tests like tests of blood and urine. Apart from this, 58 tests are listed for detection and diagnosis of a wide range of common conditions, thus providing an essential package that can form the basis for screening and management of patients.

The remaining 55 tests are designed for the detection, diagnosis and monitoring of 'priority' diseases such as HIV, tuberculosis, malaria, hepatitis B and C, human papillomavirus and syphilis, the statement said.

Some of the tests are particularly suitable for primary health care facilities, where laboratory services are often poorly resourced and sometimes non-existent.

"Our aim is to provide a tool that can be useful to all countries, to test and treat better, but also to use health funds more efficiently by concentrating on the truly essential tests, said Maringela Simo, WHO Assistant Director-General for Access to Medicines, Vaccines and Pharmaceuticals.

For each category of test, the Essential Diagnostics List specifies the type of test and intended use, format, and if appropriate for primary health care or for health facilities with laboratories.

The list also provides links to WHO guidelines or publications and to pre-qualified products.

Similar to the WHO essential medicines list, which has been in use for four decades, the essential diagnostics list is intended to serve as a reference for countries to update or develop their own list of essential diagnostics.

The WHO will update the essential diagnostics list on a regular basis. It is also expected to issue a call for applications to add categories to the next edition.

The list will expand significantly over the next few years, as it incorporates other important areas, including antimicrobial resistance, emerging pathogens, neglected tropical diseases and additional noncommunicable diseases, the statement added.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)